Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site

Click on country-registry for comparison

Flag	Country-registry	Registration period	Total	Absolute survival %			Relative survival %			ASRS% at 5-years
Flag	Country-registry	Registration period	Total	1-year	3-year	5-year	1-year	3-year	5-year	all ages	0-74 years
	China - Shangai	1992-1995	67	74.6	55.2	50.7	77.2	61.6	61.6	70.7	71.2
	China - Tianjin	1991-1999	146	89.7	81.0	78.8	92.7	90.4	95.7	101.2	93.9
	Singapore	1993-1997	44	47.7	34.1	31.5	49.3	37.0	36.1	32.4	43.9
	Republic of Korea - Busan	1996-2001	74	75.7	51.7	44.3	77.5	55.7	50.4	46.0	54.6
	Republic of Korea - Incheon	1997-2001	34	82.4	63.9	47.9	84.1	68.0	53.2	61.4	72.3
	Republic of Korea - Seoul	1993-1997	147	84.4	70.7	65.1	86.3	76.4	74.9	77.4	71.1
	Thailand - Lampang	1990-2000	39	33.3	25.6	25.6	33.6	26.2	26.6	28.0	28.0

Graphs:

1-, 3- and 5-year absolute survival (%):
sort by country / sort by survival

1-, 3- and 5-year relative survival (%)
sort by country / sort by survival

ASRS (%) all ages:
sort by country / sort by survival

ASRS (%) 0-74 years:
sort by country / sort by survival

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period